The NORML Board of Directors voted to endorse the Arizona Regulation and Taxation of Marijuana Act initiative to legalize marijuana in Arizona. That initiative has now officially qualified for the ballot in November.
Members of Congress this week heard testimony on the state of marijuana research, and leading members of the US Senate introduced legislation to potentially reclassify CBD. A medical marijuana initiative in Montana qualified for the November ballot and Governors in three states signed marijuana related bills into law. Click here to get this week’s latest marijuana news and to find out how you can #TakeAction.
How the War on Drugs Fails Black Communities
Here’s something that all Americans should agree on: Many policies have a disproportionately negative effect on black families—and, by extension, on all of us. The most insidious of them all, however, may be the war on drugs.
Philippines Drug War Out Of Control? Rodrigo Duterte Wants All […]
Over the weekend the Democratic National Committee voted to endorse a “reasoned pathway to future legalization” of marijuana and called on the federal government to downgrade marijuana from it’s current Schedule 1 of the United States Controlled Substances Act.
Post heavy consideration and consultation with family and friends — and after a serious life changing event recently — I’ve decided to resign as NORML’s executive director after some 25 years with the organization.
The enactment of statewide medicinal cannabis laws is associated with a quantifiable decline in the use of traditional prescription drugs, according to data published in the July edition of the scientific journal Health Affairs. “Ultimately, we estimated that nationally the Medicare program and its enrollers spent around $165.2 million less in 2013 as a result of changed prescribing behaviors induced by … jurisdictions that had legalized medical marijuana,” investigators reported.